OpenVSafe by OpenVAERS
Search V-safe

546-22625-87391

3 vaccinations 1 coded response 16 check-ins 1 free-text entry 1 call case
Sex
Female
Age at first dose
26-30
ZIP prefix
773 / TX
Registered
2021-12-06
Relationship
Self
Race
White
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-03-18
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-08
    Dose 2 — Pfizer-BioNTech
  3. 2021-12-06
    Registered in v-safe
  4. 2021-12-06
    Dose 3 — Pfizer-BioNTech
  5. 2021-12-06
    Health check-in — day 0, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2021-12-07
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  7. 2021-12-08
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  8. 2021-12-09
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  9. 2021-12-10
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  10. 2021-12-11
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Headache
    Adult check-in
  11. 2021-12-12
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  12. 2021-12-13
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  13. 2021-12-20
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  14. 2021-12-27
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  15. 2022-01-03
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  16. 2022-01-10
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  17. 2022-01-18
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  18. 2022-03-07
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  19. 2022-06-06
    Survey response — 6 months, dose 3
    MedDRA: Pre-eclampsia, Pregnancy — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization
    Free text: Preeclampsia with a pregnancy.
    MedDRA releases: 2024-11 · check-in free text available
  20. 2022-06-06
    Report sent to call center — 6 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Hospitalization · 1 call case(s)
  21. 2022-06-07
  22. 2022-12-06
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-18Pfizer-BioNTech No
22021-04-08Pfizer-BioNTech No
32021-12-06Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2022-06-06 Unsuccessful

Free text

Release 11 — 6 months, dose 3

2022-06-06

Symptoms: Preeclampsia with a pregnancy.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDPre-eclampsia · · ✓
SDPregnancy · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…